PRESENTATION

FY2022 — Results presentation

FY2022PDF · 66 pages5.9 MB
AUDITED
RESULTS
for the year ended 30 June 2022

-- 1 of 66 --

2
+5% new business API, including DH take-
on of new closed schemes and gross
revenue for Vitality Group
Core new
business
+6%
to R21 710m
Normalised
operating profit
+45%
to R9 384m
Normalised
headline earnings
+71%
to R5 816m
Headline
earnings
+74%
to R5 204m
GLOBAL

-- 2 of 66 --

3
30 years of organic growth
-
1 000
2 000
3 000
4 000
5 000
6 000
7 000
8 000
9 000
10 000
Operating profit (Rm)
R9 384m
Operating profit
“Make people
healthier and
enhance and
protect their lives”

-- 3 of 66 --

4
Navigating
COVID-19
Inflation,
recession,
market
volatility
Russia-Ukraine
war and geo-
political
tensions
Period saw increased macro environment uncertainty
High inflation
CPI inflation rates
-2%
0%
2%
4%
6%
8%
10%
Jul-20
Oct-20	
Jan-21	
Apr-21	
Jul-21
Oct-21	
Jan-22	
Apr-22
SA US
UK China
FY 2022	FY 2021
Indices rebased to July
2020
80
90
100
110
120
130
140
150
160
Jul-20
Oct-20	
Jan-21
Apr-21	
Jul-21
Oct-21	
Jan-22
Apr-22
SWIX (SA)
S&P 500 (US)
SSE (China)
FTSE 100 (UK)
FY 2022	FY 2021
Market volatility	Rising interest rates
0.0%
0.5%
1.0%
1.5%
2.0%
2.5%
0%
2%
4%
6%
8%
10%
12%
14%
Jun19	
Dec19	
Jun20	
Dec20	
Jun21	
Dec21	
Jun22
SA single nominal rate
UK 25 yr SONIA Swap
SA and UK
FY22	FY21	FY20
COVID-19 deaths
0
2,000
4,000
6,000
8,000
10,000
12,000
14,000
16,000
18,000
Jun-20	
Oct-20	
Feb-21	
Jun-21	
Oct-21	
Feb-22	
Jun-22
SA excess deaths
FY 2022	FY 2021

-- 4 of 66 --

5
Positioned for growth off a strong foundation
1
2
3
4
Robust growth, navigating COVID-19
and macroeconomic volatility
Pivoting off the Shared-value model
to manage the complexities of the
period under review
Scaling and streamlining the New
initiatives
Ensuring capital strength and
liquidity
R77bn
Gross income
470m
Healthy
activities
R9.4bn
Profit
R21.7bn
New business
39
Markets
>30m
Customers
1 business model
13 552
People
The leading new generation financial services organisation which through its Vitality Shared-value
model makes customers healthier, provides better and more sustainable products, achieves superior growth
and returns for its shareholders and is a force for good in the communities in which it operates

-- 5 of 66 --

6
Strong operating profit growth despite COVID-19 and organically
building New initiatives
Operating profit
Rm
-
2,000
4,000
6,000
8,000
10,000
12,000
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
+45%
Investment in New
Pandemic
Macro
-
2,000
4,000
6,000
8,000
10,000
12,000
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
SA COVID-19 provision impact Investment New

-- 6 of 66 --

7
Health 3 600 +5% 7 292 +20%
Life 4 028 +200% 2 543 +12%
Invest 1 204 +11% 2 920 +7%
Insure (162) -165% 1 246 -3%
Core SA 8 670 +42% 14 001 +13%
Vitality Health 1 328 +39% 1 738 +27%
Vitality Life 671 +4% 1 256 +10%
Core UK 1 999 +25% 2 994 +19%
Vitality Group 473 +13% 1 398 +10%
Ping An Health 338 -18% 2 883 -15%
Core VG 811 -2% 4 281 -8%
Bank (990) -10%
Other New (1 115) +14% 1 576 -25%
+6%
Core new business API*
R21.7bn
+45%
Operating profit
R9.4bn
Strong growth
ZARm
Insurance entities only
*Core new business API excludes DH take-on of new closed schemes and gross revenue for Vitality Group
Robust profit growth and excellent new business growth. DHMS’ pricing strategy continues to
balance short-term affordability with long-term sustainability
Resilient performance driven by positive overall experience and COVID-19 experience
consistent with provision modelling
Robust performance despite lower market levels over second half of period. Launched
Cogence, SA’s first Shared-value DFM with BlackRock (Aladdin WealthTM Technology)
Difficult period, R369m claims overrun, mainly due to adverse weather events, notably KZN
floods, combined with motor parts inflation dramatically exceeding CPI
Excellent operating performance driven by sustained membership growth, rigorous expense
controls and excellent care management
Robust performance as a result of management actions taken over previous reporting periods.
Concluded the long-term deferral of the Part VII transfer of VL
Strong growth from existing operations and operating model efficiencies unlocked by formation
of Vitality Network and Vitality Health International
PAH generated R1.3bn lower investment income than prior period however business
fundamentals remain strong. New business on PAH insurance licence increased; total new
business reduced due to restructuring in the co-operation with PAL
18% of Group operating profit on New led by Discovery Bank. Streamlined some New initiatives
to ensure focus on the businesses that generate significant economic value
Bank continues to expand its current client base, and reached 1m accounts in the period

-- 7 of 66 --

8
Estimated CFR like seasonal flu
during 4th and 5th waves
COVID-19 less lethal however increased morbidity risk
No evidence of increased mortality
post-infection
However, 1.4x higher risk of
hospital admission post-infection
0.00%
0.02%
0.04%
0.06%
0.08%
0.10%
0.12%
0.14%
0.16%
-11 -9 -7 -5 -3 -1 1 3 5 7 9 11
Months prior
infection
Months since
recovery
No evidence of
increased mortality
post infection
96x higher
mortality risk In
the period of
infection
1. Source: Discovery Health Insights Initial analysis. To be submitted for peer review and publication
2. Assessed using COVID19 recovered clients randomly matched to individuals with no infection on recovery date, using the following features: age, sex, co-morbidity count, vaccination status, region, disease burden index, benefit option, prior flu vaccinations, oncology and chronic renal failure status. Population and matched controls are censored if either twin experiences scheme
withdrawal or COVID19 infection.
Recovery date based on the latter of 10 days post PCR collection date or COVID19 admission discharge date.
0.0%
0.5%
1.0%
1.5%
2.0%
2.5%
3.0%
3.5%
4.0%
4.5%
5.0%
-11 -9 -7 -5 -3 -1 1 3 5 7 9 11
2.4x higher admission
risk 1 month post
recovery
1.4x higher
admission risk 2-12
months post
recovery
24x higher admission
risk in the period of
infection
Months prior
infection
Months since
recovery
Mortality rate following confirmed
infection
1.02%
2.07%
1.61%
0.13%
D614G Beta Delta Omicron
Season Flu CFR Range CFR
1 x
Flu
7 x
Flu
11 x
Flu
14 x
Flu
R-factor
1.5 R-factor
2.3-4
R-factor
1.6 R-factor
1.6

-- 8 of 66 --

9
Significantly de-risked the claims and lapse basis
to allow for endemic COVID-19 and other risks
Life companies were resilient throughout the pandemic
Gross COVID-19 claims
paid
R7.2bn
Discovery Life and VitalityLife
-
1,000
2,000
3,000
4,000
5,000
6,000
7,000
8,000
FY20 FY21 FY22 Total
Both DL and VL in strong
position
VLL SCRC
182% 183% 174%
FY20 FY21 FY22
DL SCRC
197%
243% 214%
FY20 FY21 FY22
330
144
Claims Lapses
Short-term basis
Long-term basis
550
294
Discovery Life estimated 1-year impact for FY23 of basis
strengthening
Rm Claims:
• Strengthening of long-term mortality,
capital disability and severe illness
basis
• Short-term stress assumptions to
allow for heightened direct and
indirect COVID-19 risks
In addition:
Refinements to shared-value model and
other interventions significantly de-risks
the basis
Lapses:
• Short and long-term adjustments to
basis
• Explicit policy alteration allowance

-- 9 of 66 --

10
Focus on scaling the key initiatives and streamlining the marginal ones
Discovery Bank
Discovery
Business
Insurance
Umbrella
Funds
VitalityInvest
Discovery
Connect
Expect continued
growth
Cogence
AIA Health
accounts
>1m
Expect rapid growth, 9
captive markets with
50m clients
total staff
194
Modularising V1
services to make it more
accessible and sellable	V1 markets
24
Will be folded into
businesses
Despite strong growth,
exiting VI due to market
conditions
Reviewing AIAH (Australia)
to focus on Amplify Health
strategy across Asia
1
Region
Large scale	
initiatives
Embedded in
businesses
Strategically
reviewing
Size Prospects
DBI API
R350m
UF FUM
R8.9bn
new clients
a day*
c1-in-2
VitalityInvest
AUA
R15bn
AIAH lives
>50k
*Connect new individual clients a day
active
clients
74% deposit vs
loan book
2x
deployment
underway
1st
lives
2.3m

-- 10 of 66 --

11
0%
5%
10%
15%
20%
25%
30%
2018 2019 2020 2021 2022
Bank Other SA UK VG
Majority in Bank, expect spend to revert to long-term guidance
47%
13%
17%
23%
Bank Other SA VG UK
c60% of New is in Bank and Vitality Group
New by strand
Investment in New has been above guidance
% core operating profit

-- 11 of 66 --

12
100 82 67 53
Bronze Silver Gold Platinum
100 78 66 53 41
Blue Bronze Silver Gold Diamond
100
53 46 33
Blue Bronze Silver Gold
Discovery Health retention by status
Vitality Shared-value model resilient during complex times
Excellent
persistency
Resilience
to COVID-19
Unexpected
correlations
Clear causality
Discovery Life COVID-19 CFR by status
Discovery Insure weather claims frequency by status
Discovery Bank default rates by status
Stability and
positive selection
Discovery Life claims and lapses
At least partially vaccinated by status (%)
Vitality Health lapses by status
VG partner market claims and lapses
Discovery Bank deposit by status
100
68 52 75
43
Blue Bronze Silver Gold Diamond
Discovery Insure claims and lapses
100 85 75 60
Blue Bronze Silver Gold and
Diamond
100 85 58
26
Blue Bronze Silver Gold and
diamond
100
27 18 13
Blue Bronze Silver Gold
100
44 29 22 20
Blue Bronze Silver Gold Diamond
100
73 73 57 45
Blue Bronze Silver Gold Diamond
100 86 70 65
Blue Bronze Silver Gold and
Diamond
100
28 6 4
Blue Bronze Silver Gold and
Diamound
1 2 11
64
Blue Bronze Silver Gold and
Diamond
Vitality Life COVID claims as % total
100
25 5 13
Bronze Silver Gold Platinum
64 76 80 82 86
Blue Bronze Silver Gold Diamond

-- 12 of 66 --

13
Creating repeatability in the Vitality shared-value health insurance
model
Discovery Health
Health
Vitality Health
International
USA

-- 13 of 66 --

14
𝐶𝑙𝑎𝑖𝑚𝑠 𝑠𝑎𝑣𝑒𝑑
𝑀𝑎𝑟𝑘𝑒𝑡 𝑠ℎ𝑎𝑟𝑒
𝑐𝑜𝑠𝑡 𝑜𝑓 𝑓𝑖𝑙𝑙𝑖𝑛𝑔
𝑝𝑜𝑡ℎ𝑜𝑙𝑒>
112 448 Potholes filled since inception

-- 14 of 66 --

15
Opening EV Value of new
business
Unwind of risk
discount rate
Non-Economic
Experience
Variances and
Methodology &
Assumption
Changes
COVID-19 impact Operational EV Economic
Experience
Variances and
Methodology &
Assumption
Changes
Forex New Initiatives Other Closing EV
14.8%
Group Embedded Value
R86 258m	R87 293m
R74 645m
Operational EV Economic and other
ROEV

-- 15 of 66 --

16
15%
20%
25%
30%
FY18 FY19 FY20 FY21 FY22
Group is well capitalised and highly liquid
1 Capital Adequacy Ratio
2 Comprehensive Cover Ratio, FY21 on C-ROSS I and FY22 on C-ROSS II
3 Considers SA Liquidity and liquid excess assets for Discovery Life, Discovery Insure, VitalityHealth, VitalityLife and Discovery Bank
4 SA cash + undrawn committed facilities
SA Liquidity4, R millions
FLR R millions
Liquid excess assets above minimum
regulatory capital requirements
Strongly capitalised FLR within target
Highly liquid across
the Group3
Sufficient liquidity
at the centre
DHMS solvency
(unaudited)
36%
23.8%
28%
Jun 21
Cover
Jun 22
Cover
Life 1.8x 1.7x
Insure 1.8x 1.2x
VH 1.6x 1.5x
VL 2.4x 2.1x
Bank1 1.4x 1.3x
PAH2 2.3x 2.8x
-
500
1,000
1,500
2,000
2,500
3,000
FY18 FY19 FY20 FY21 FY22
-
2,000
4,000
6,000
8,000
10,000
12,000
14,000
16,000
FY18 FY19 FY20 FY21 FY22

-- 16 of 66 --

17
Reported profit for the period affected by a few key factors
Discovery Board continues to retain
prior stated dividend position and
decided not to declare an ordinary final
dividend for the period ended 30 June
2022. The reintroduction of an ordinary
dividend will be considered on an
ongoing basis
Rm
12 months
ended
12 months
ended
%	Jun-22 Jun-21
Normalised profit from operations 9 384 6 494 45%
Economic assumptions adjustment - DL ( 651) ( 411)
Economic assumptions adjustment – VL (net of all hedge impacts) 113 31
Finance charges excl. 1DP finance lease (1 376) (1 291)
Unrealised gains/(losses) on foreign exchange contracts not designated as a hedge ( 2) ( 304)
Foreign exchange gains/(losses) 155 ( 389)
Expenses related to Prudential Book transfer ( 182) ( 187)
Investment income and fair value remeasurements 210 83
Vaccination costs ( 157) ( 42)
Gains from dilution of equity accounted investments 33 554
Other ( 258) ( 331)
Profit before tax 7 269 4 207 73%
Tax (1 790) ( 987)
Profit attributable to preference shareholders ( 57) ( 63)
Profit attributable to equity holders 5 422 3 157 72%
Headline adjusting items ( 218) ( 171)
Headline earnings 5 204 2 986 74%
Economic assumptions adjustment (DL and VL) after tax and hedging 377 270
Other normalisation adjustments after tax 235 150
Normalised headline earnings 5 816 3 406 71%
1
2
3
1
2
3
SA saw an increase in nominal interest
rates which partly recovered by 31
August 2022
UK saw increase in long term interest
rates which benefits the business,
partially offset by hedge effects and
transfers to discretionary margin
Weakening of the Rand compared to a
strengthening in the prior period
Continued investment in supporting
the national vaccination campaign in
SA

-- 17 of 66 --

18
Driving our purpose as a force for good in a complex ESG space
Making people healthier
1
Restoring the climate and
environment
Strengthening healthcare system & nation
building
Ensuring diverse and inclusive
workforce
Ensuring fair and responsible
pay
2
3
4
5
Focus areas and FY 2022 outcomes
470m >2m R11.4bn
Healthy activities recorded1 Life years saved2 Shared-value dividend3
Lowest
Carbon emitter4,5
17%
Lower carbon emissions5
10%
of medical sub-specialists trained6
of which 75% are in the public sector R200m
Spend on mass vaccination campaign7
Female Black
Staff 62% 84%
Leadership 52% 64%
Executive leadership 45% 36%
2nd of 14
Lowest income disparity ratio8
ESG Ratings
Peer rating4
Highest 19.8 74%	71%
2022 2022	2021
1 Healthy activities include moderate and intense physical activity events recorded and HealthyFood purchases; 2 Life years saved is calculated from healthy activities recorded, using the methodology in the Rand research paper;
https://d16pi0tqkfzkv3.cloudfront.net/assets/microsites/vitality-international/pdfs/rand-rr2870.pdf ; 3 Includes R5.2bn and R4.7bn Shared-value and rewards returned to customers respectively and R1.5bn DHMS dividend from Vitality; 4 Relative to domestic
life insurance peer group; 5 Relative to 2019 base, measured by Scope 1 + Scope 2 emissions, before verification ; 6 Based on 10-year analysis, performed prior to 2022; 7 FY21 and FY22; 8 Relative to SA financial services group
4,8

-- 18 of 66 --

Growth in the three
market-specific
strategies

-- 19 of 66 --

20
1
2
3
The strategic strands
Perfect composite model, #1 in our chosen segments in every industry, and the Bank pivoting to growth as
the composite-maker within SA
Best-in-breed products across businesses and operating as a fully integrated composite business with a
seamless One Vitality client journey. A successful entry into motor insurance
Leading wellness and healthcare platform that provides preeminent life and health insurers globally with our
Vitality shared-value and health management capabilities to assist them in making their customers healthier,
while ensuring their products are more competitive with better margins
Discovery Insure	
Discovery Life	
Discovery Invest	
Discovery Bank	
Discovery Health	
Vitality Health	
Vitality Car	
Vitality Life
USA

-- 20 of 66 --

21
Discovery Insure	
Discovery Life	
Discovery Invest	
Discovery Bank	
Discovery Health

-- 21 of 66 --

22
Jul-19
Nov-19	
Mar-20
Jul-20
Nov-20	
Mar-21
Jul-21
Nov-21	
Mar-22
Total clients Total accounts Retail deposits Advances Operating result
>510k >1.1m R11.2bn R4.5bn -R990m
Discovery Bank
2018* 2019* 2020 2021 2022
Headline figures as at August 2022; operating result as at June 2022
*Includes capital development costs during
build phase
Jul-19
Nov-19	
Mar-20
Jul-20
Nov-20	
Mar-21
Jul-21
Nov-21	
Mar-22
Jul-19
Nov-19	
Mar-20
Jul-20
Nov-20	
Mar-21
Jul-21
Nov-21	
Mar-22
Jul-19
Nov-19	
Mar-20
Jul-20
Nov-20	
Mar-21
Jul-21
Nov-21	
Mar-22

-- 22 of 66 --

23
Key focus areas for the Bank
Full-service
offering
1 Differentiation
and growth
Shared-
value
2 Quality and
revenue
3 Digital
capabilities Functionality
and economics

-- 23 of 66 --

24
57%
26%
10%
4%
New to Discovery
1 Product
2 Products
3 Products
4+ Products
-
100
200
300
400
500
600
700
800
900
1,000
Jan-20
May-20	
Sep-20	
Jan-21
May-21	
Sep-21	
Jan-22
May-22
Growth of >800 clients per day with high engagement
Close to 1 000 daily
new business sales
57% new to
Discovery
iOS banking app
download share
>800
0%
50%
100%
Jul-21 Jun-22
Self-assisted Direct
Intermediated
Intermediated
sales grew
Jul-21 Dec-21 Feb-22 Jun-22
FNB Standard
Bank Absa
Capitec Nedbank Discovery
74% clients are
primary or active
In line with DH’s 40% market
share of open and closed
schemes
• Primary / highly active – ≥15% of net
income as spend – for primary clients,
salary deposits/ equivalent inflow
• Active – <15% of net income as spend
• Inactive – No activity or not in good
standing
Average daily new business sales
per business day New business composition Engagement mix	Channel mix
34%
40%
26%
Primary / highly active
Active
Inactive	New or low active

-- 24 of 66 --

25
Increasing credit penetration with superior credit quality
New credit card market
share by income pm
New credit business by
risk tier
69%
49%
15%
19%
7%
14%
9% 17%
Market Discovery
Exceptional low risk
Low risk
Medium risk
High+ risk
Bank A Bank B Bank C
Bank D Bank E DSY
23%
14%
6%
2%
Q1
FY21
Q2
FY21
Q3
FY21
Q4
FY21
Q1
FY22
Q2
FY22
Q3
FY22
3.5%
7.4%
New credit market
share
Credit loss ratio vs
market
5.10%
2.20%
Big 4 average Discovery (incl
overlays)
As at Jun-22; FRB as at Dec-21 (Integrated Annual Reports)

-- 25 of 66 --

26
80%
90%
100%
110%
120%
Q2
FY21
Q3
FY21
Q4
FY21
Q1
FY22
Q2
FY22
Q3
FY22
Q4
FY22
Cost of funds
Retail net interest margin
Revenue growth and digital scalability driving operating leverage
Operating
leverage
Indexed to Jan-21
Breakeven earnings
and sensitivities
Strong revenue
growth
Bank 1
DSY
Big 4
average
Bank 2
Bank 3
Bank 4
Gross NIR pcpm vs
market
+19%
Net interest
margin
117%
Indexed to Q2 FY21
92%
Q1 FY21 excluded due to billing anomalies during
the BIN migrations
As at Jun-22; FRB as at Dec-21 (Integrated Annual
Reports)
30%
40%
50%
60%
70%
80%
90%
100%
110%
120%
Jan-21	
Mar-21	
May-21
Jul-21
Sep-21	
Nov-21	
Jan-22	
Mar-22	
May-22
Expenses pcpm
Gross NIR pcpm
Loss before tax pcpm*
67%
107%
40%
R1.2bn
FY22 FY23 FY24 FY25 FY26 FY27
Base Stretch Upside
Daily sales : 1.2k by FY24 (stretch), 1.5k by FY25 (upside)
Advances: +5% (upside)
CLR: -5% (upside)
NIR pcpm: +4% (stretch), +6% (upside) from FY24
*Once-off adjustments allocated evenly over the
financial year
Total revenue FY22
0
50
100
150
200
250
300
350
400
Q1
FY21
Q2
FY21
Q3
FY21
Q4
FY21
Q1
FY22
Q2
FY22
Q3
FY22
Q4
FY22
Total NII Gross NIR

-- 26 of 66 --

27
The case for the composite
Discovery
Life
Discovery
Health
Discovery
Insure
Discovery
Invest
30%
market
share
50%
market
share1
Top 3
New business
growth3
3rd
largest in net
flows2
R1.5bn
Financial impact
of the Vitality
wellness program
on DHMS in 2021
R3.7bn
Premium
discounts and
cash paybacks
paid in FY22
R223m
Premium
discounts and fuel
cash backs paid in
FY22
R1bn
Fee discounts,
boosts and
paybacks paid in
FY22
Discovery Bank
Same architecture
Consumer use; digital ecosystem
and engagement platform
Security and integrated payment
systems
Discovery Miles store of value
Shared-
value
created
Market
share
Same
architecture HEALTH HEALTH DRIVE
1 DH market share excluding GEMS, 39% including GEMS
2 Excluding white labelled funds
3 based on best estimate of competitor new business numbers
Discovery	
Life	
Discovery	
Health	
Discovery	
Insure

-- 27 of 66 --

28
SA Composite
Single-view,
consistent architecture
and unique
digital capabilities

-- 28 of 66 --

29
Discovery Insure	
Discovery Life	
Discovery Invest	
Discovery Bank	
Discovery Health

-- 29 of 66 --

30
Discovery Health
Membership Non-scheme growth Operating profit	New business
to R7 292m
+20%
lives under administration
>3.7m to R3 600m
+5%
lives
>263k
revenue
R1.2bn
1993	
1995	
1997	
1999	
2001	
2003	
2005	
2007	
2009	
2011	
2013	
2015	
2017	
2019	
2021
Non Scheme Products
Restricted Schemes
DHMS
2018 2019 2020 2021 2022 2018 2019 2020 2021 2022
Jan-18	
Jun-18	
Nov-18	
Apr-19	
Sep-19	
Feb-20
Jul-20
Dec-20	
May-21	
Oct-21	
Mar-22
Flexicare
Gap Cover
Healthy Compay	Healthy Company

-- 30 of 66 --

31
DHMS
Discovery Health Medical Scheme performance summary
Membership Flight to stability persists Solvency
market share:	57.6%
credit rating
AAA
unaudited
reserves
at June 2022
R28.3bn
0%
2%
4%
6%
8%
10%
12%
2018 2019 2020 2021 2022
Stable lapses
5.2%
Resilient membership base
1
DHMS Rest of
Industry
Others
94.6%
2.9% 2.5%
94.5%
2.6% 2.9%
94.6%
2.4% 3.0%
96.5%
1.9% 1.6%
96.8%
1.7% 1.6%
2018: 2019: 2020:
2021: 2022:
0%
5%
10%
15%
20%
25%
30%
35%
40%
-
5
10
15
20
25
30
35
2018 2019 2020 2021 2022
R billion
Reserve Actual Solvency Required Solvency
R6.8bn returned to
members through deferred
contribution increases
unaudited
solvency
at June 2022
36%
Annualised lapse rate excludes turnover members: i.e. members from existing employer
groups who leave their employment and are subsequently replaced.

-- 31 of 66 --

32
Growth deep-dive
Growth from all types of
business
DHMS growth in stark contrast
to market
Higher levels of Vitality-
integrated DHMS policies
2020 2021 2022
2.1x improved surplus per life
Vitality members contribute significantly to
the overall health of the scheme:
15% lower admission rates
38% lower lapses
2018 2019 2020 2021 2022
57% from employer groups:
43% from individuals:
2018 2019 2020 2021 2022
Heathier new joiner profile:
DHMS Open Schemes
Average age 26.1 27.6
Chronic ratio 6.5% 9.3%
Gross, net and withdrawing lives over last 18
months
1	Gross lives
Left
employer
Affordability
Provider change
Death
Emigration
Other
+241k
gross +46k net
Withdrawing
& net lives

-- 32 of 66 --

33
Discovery Connect | End-to-end D2C capability powered by
industry-leading technology and analytics
Strong in-force policy growth reflecting
the quality of new business
Health connect sales as % of individual
policies sales from FY16-FY22
Jul-17
Nov-17	
Mar-18
Jul-18
Nov-18	
Mar-19
Jul-19
Nov-19	
Mar-20
Jul-20
Nov-20	
Mar-21
Jul-21
Nov-21	
Mar-22
Jul-22
2.6x
336
877
In-force book (policy-lives ‘000, all products activated
via Connect)
0%
10%
20%
30%
40%
50%
60%
70%
FY16 FY17 FY18 FY19 FY20 FY21 FY22

-- 33 of 66 --

34
DHMS: An industry-first activation journey
ADVANCED AI-
DRIVEN PLAN
SELECTION
OPTIMISED
CUSTOMER JOURNEY AUTOMATED,
EFFICIENT
UNDERWRITING
SECURE
PROCESS
IMMEDIATE
ACTIVATION

-- 34 of 66 --

35
Discovery Insure	
Discovery Life	
Discovery Invest	
Discovery Bank	
Discovery Health

-- 35 of 66 --

36
SCR
coverage
174%
2022
3,112
2022
1xILT
Liquidity
coverage
125%
SCR target
29.0%
30.2%
Discovery Life
Normalised operating profit
to R4 028m
+200%
Strong capital
and liquidity
2018 2019 2020 2021 2022
New business API
to R2 543m
+12%
Maintained leading
market share position
NMG Market Share survey Q1+Q2 2022
2016 2017 2018 2019 2020 2021 2022
First 6 months of 2021
First 6 months of 2022

-- 36 of 66 --

37
Discovery Life remained resilient through COVID-19
Jun 2020	
Aug 2020	
Oct 2020	
Dec 2020	
Feb 2021	
Apr 2021	
Jun 2021	
Aug 2021	
Oct 2021	
Dec 2021	
Feb 2022	
Apr 2022	
Jun 2022
Wave 1 =
R538m
Wave 2 =
R1 871m
Wave 4 =
R373m
Wave 3 =
R3 940m
Wave 5
= R108m
Provisions sufficient	Gross claims paid decreased
substantially during H2 FY22
FY21 FY22
IFRS claims provision
utilisation*	96%
*Excludes IBNR of 4%
Individual Life total COVID-19 provision
available vs utilisation
22
1,673 1,769
0
1,976
2,398
FY20 FY21 FY22
Net COVID-19 Claims
Provision available in period
Claims
 
Lapses
Lapses
Claims
Gross claims
paid in FY22	R3.7bn
Cashflow impacted by COVID-19
claims
Rm
Premium and fees
Claims
Operational costs
Cashflows from existing
New business strain and net
finre
Net cashflow excl COVID-19
COVID-19 Impact
Net cashflow after COVID-19
869
3 629
17 478
-245
R869m
Net cashflow
before COVID-19

-- 37 of 66 --

38
658
Lapses and surrenders	
Mortality and morbidity
Premium and fee income
Policy alterations
Other
Total
Embedded value growth driven by positive operating variances
to R38.4bn
Life and Invest embedded value
Rbn
+10.5%
VNB and margin impacted
by higher interest rates and
lower volumes
Positive non-economic
experience variances
Life & Invest FY 2022 (Rm)
411
365
2021 2022
5.7%
5.3%
2021 2022
VNB (Rm)
Life:
VNB margin
(%) Life:
Persistency offset higher
than expected morbidity
experience
June 2021
New business
Expected unwind incl New
Business
Experience Variances
Methodology and Assumption
Changes
Total before Economic Impact
Experience Variances
Methodology and Assumption
Changes
Components below the line
June 2022
34.8bn
38.5bn 38.4bn
Economic
Non-
economic

-- 38 of 66 --

39
Discovery Insure	
Discovery Life	
Discovery Invest	
Discovery Bank	
Discovery Health

-- 39 of 66 --

40
Discovery Invest
+7%to R2 920m
2018 2019 2020 2021 2022
+11%to R1 204m
+4%
10%
lower income drawdowns
43%
lower investment lapses
in shared-value benefits
accrued and paid to
clients
R13.3bn
Since the launch of shared
value:
2018 2019 2020 2021 2022
2018
2019
2020
2021
2022
to R122bn
H1 H2
Shareholder
Weighted All
Share
6.6% -7.2%
S&P 500 Index
(USD) 10.9% -20.6%
NASDAQ
Composite
(USD)
7.9% -29.5%
Assets under
Administration 9.5% -4.6%
Market volatility in
H2 affected AuA
growth
Normalised
operating profit
Assets under
administration
Shared-value
outcomes
New business

-- 40 of 66 --

41
World’s first shared-value DFM with BlackRock and RisCura
providing independent fund selection with boosts on the
entire solution
Combination of factors led to
opportunity for shared-value
behavioural investment platform
ACCESS THE WORLD’S BEST INVESTMENT
CAPABILITIES THROUGH BLACKROCK
113
Markets across
the globe
$472 bn
BlackRock sustainable
AUM*
UNDERPINNED BY ALADDIN WEALTH™
TECHNOLOGY
2 100+ 3 000+
Dedicated
developers and
product managers
Risk factors
monitored daily
USE VITALITY TO PROVIDE PATHWAYS
TO BETTER RETIREMENT
*Source: BlackRock as at June 2022
Transfer of risk to investors
through Defined Contribution
funding plans
Technology platforms
democratising asset
management capabilities
Increase in complexity of
investment markets
Behavioural and demographic
risks are important but have
largely been ignored

-- 41 of 66 --

42
Discovery Insure	
Discovery Life	
Discovery Invest	
Discovery Bank	
Discovery Health

-- 42 of 66 --

43
2018 2019 2020 2021 2022
Discovery Insure
Gross new
business
Gross written
premium
to R4 762m1 to R1 246m2
2018 2019 2020 2021 2022
1 Personal lines figures only
2 Figures excluding VAT
3 Normalised operating profit includes Personal lines and Cambridge Mobile Telematics
-3%	+13%
Market share
in GWP
Assuming 6% annual market growth
7%
Vehicles insured
+5%to 296 0001
Normalised
operating profit
to –R162m3
-165%
2018 2019 2020 2021 2022
CMT Personal lines
2018 2019 2020 2021 2022
2018 2019 2020 2021 2022

-- 43 of 66 --

44
Adverse weather and supply-side inflation had the largest claims impact
1 Shipping cost index: https://fbx.freightos.com
2 El-Nino Southern Oscillation Index. Jul 2022 to Dec 2022 numbers are predictions: https://origin.cpc.ncep.noaa.gov/products/analysis_monitoring/ensostuff/ONI_v5.php/
Contribution to total claims overrun
$-
$2
$4
$6
$8
$10
$12
Thousands
Rapid rise in shipping costs1
100
85 75
60
Blue Bronze Silver Gold and
Diamond
Relative motor claim severity
by status
4x
0% 5% 10% 15% 20%
A
B
C
D
E
F
G
H
I
J
Vehicle make
2021 2022
Adverse weather | Longer rainy season and KZN floods
Longer rainy season increased
claim costs2
KZN storm: the largest CAT
event in Insure history
100
86
70 65
Blue Bronze Silver Gold and
Diamond
Relative weather claim
frequency by status
Jan-10	
Jan-11	
Jan-12	
Jan-13	
Jan-14	
Jan-15	
Jan-16	
Jan-17	
Jan-18	
Jan-19	
Jan-20	
Jan-21	
Jan-22
 -
50
100
150
200
Feb 15	
Nov 15	
Jan 16	
Feb 16
Jul 16	
Nov 16	
Jun 17	
Oct 17	
Dec 17	
Apr 19	
Dec 19	
Apr 22
Rm
FY22-23
High motor parts inflation for
top 10 vehicle makes
Supply-side inflation | Motor inflation exceeded expectations	R369m claims overrun due to
adverse claims experience
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Adverse
Weather
Supply
side
Inflation
Power
surge
Other Total
claims
overrun
44%
Adverse
weather
28%
Supply-side
inflation

-- 44 of 66 --

45
Corrective actions implemented to manage impact
Selective lapsation
experienced
90%
95%
100%
105%
110%
Actual Premium
Projected premium with H1 growth
Higher average
premium growth
60%
70%
80%
90%
100%
110%
120%
Premium growth AvE lapse experience
98
258
Retained clients Excess lapses
2.5x
Quality client base
retained
Relative historical loss ratios
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Additional
margin
generated
Repeatable
claims
Net
position
Actions generated
additional margins
Claims relative to margin
Lapses by status
74%
Blue Bronze Silver Gold and
diamond
Gold and
Diamond

-- 45 of 66 --

46
Vitality Health	
Vitality Car	
Vitality Life

-- 46 of 66 --

47
Lives covered
UK Composite
Normalised
operating profit
New business
GBP millions	
GBP millions	
GBP millions
Best-in-breed products
across businesses and
operating as a fully
integrated composite
business with a seamless
One Vitality client journey
to £893m	to £98.7m
+28% +8% +12% +22%
to £148.1m	to 1.56m lives
2018 2019 2020 2021 2022 2018 2019 2020 2021 2022
Vitality Health, Vitality Life, Vitality Car
1 Vitality Health and Vitality Life only
Earned
premiums1
2018 2019 2020 2021 2022 2018 2019 2020 2021 2022
Vitality Health	
Vitality Car	
Vitality Life

-- 47 of 66 --

48
Consolidated UK Embedded Value
Opening as at
30 Jun '21
VL Part VII
Delay
Experience
variances
Assumption
changes
Methodology
and
modelling
changes
Shareholder
capital
injected
Other Closing as at
30 Jun '22
£72.5m £35.5m
£45.4m
£12.6m £9.0m £37m £1 002m
£790m
2019 2020 2021 2022
Consolidated UK EV
Exceeding the £1 billion mark
£1 002m
£790m
£735m
£840m
Robust performance through
the pandemic

-- 48 of 66 --

49
Vitality Health
Normalised
operating profit
Earned premiums Lives covered New business
GBP millions	
GBP millions	
GBP millions
to £560.2m	to £65.6m
+43% +9% +15% +30%
to £85.8m	to 839k lives
2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022

-- 49 of 66 --

50
Lives
2019
New
business
growth
Retention Lives
2022
Lives
2019
New
business
growth
Retention Lives
2022
Deploying data-driven approaches in an excellent operational
environment to amplify benefits across the value chain
Attract Price Engage Retain
Advanced analytics and ML
models support direct
sales activity and
advertising investment
Price optimisation and
personalised pricing drive
profitable new business
and renewals
ML models drive
personalised wellness
recommendations;
sophisticated digital tools
aid health system
navigation
ML models and advanced
analytics drive proactive
retention
Profit uplift=
2019 2022
£560m
£460m
16%
Of membership
growth
attributable to
new business
growth
22% Increase in
earned
premium
84%
Of membership
growth
attributable to
retention
performance
16%
642k
839k	84%
22%
30% Operating
margin uplift
Earned premium
uplift
Increase in
normalised
operating profit
58%
=
Musculoskeletal
Oncology
Cardiac
-31%
-37%
-46%
Engagement driving down
healthcare costs
Active Rewards points
839k
642k

-- 50 of 66 --

51
Strategically positioned to further enhance a strong presence in
the UK healthcare environment
NHS waiting list has been growing
Demand for VH’s Primary Care services
has grown substantially
Total number of people waiting to begin treatment Percentage of claims that are Primary Care
0%
10%
20%
30%
40%
50%
2015 2016 2017 2018 2019 2020 2021 2022
Vitality GP Talking Therapies Physiotherapy
Over 45%
in 2022
Source: NHS England Statistical work areas
0
1,000,000
2,000,000
3,000,000
4,000,000
5,000,000
6,000,000
7,000,000
8,000,000
6.7 million
People waiting to
receive treatment

-- 51 of 66 --

52
Vitality Life
Normalised operating
profit
Earned premiums Lives covered New business
to £333m
+7% +9%
to 722k lives
GBP millions	
GBP millions	
GBP millions
to £33.1m
+7% +13%
to £62.3m
2018 2019 2020 2021 2022 2018 2019 2020 2021 2022	2018 2019 2020 2021 20222018 2019 2020 2021 2022

-- 52 of 66 --

53
0.0%
0.5%
1.0%
1.5%
2.0%
2.5%
3.0%
Jul-21 Oct-21 Jan-22 Apr-22 Jul-22
Significantly strengthened the back book
Bronze Silver Gold Platinum
Successful deferral of
Part VII
Hedging strategy
recouped past
interest rate losses
Exceptionally strong
retention
performance
Strong shared-value
dynamics through the
pandemic
Jul-19 Feb-20 Sep-20 Apr-21 Nov-21 Jun-22
Expected
-25%
Lapses AvE
-13% -19%
-51%
25 Year Swap Rate for FY22
Swaption began
generating value
at 1.15%
Liquidity timing risk
Effective hedging
directly on Prudential
Balance Sheet
Capital Risk to do Part
VII
Operational complexity
Sustainable commercial
terms
After	Before
1
2
3
4
5
Part VII transfer now indefinitely
deferred, de-risking the business
going forward
Bronze Silver Gold Platinum
AvE mortality rates for optimised
policies
AvE lapse rates for optimised policies
-25% -16%
-47%

-- 53 of 66 --

54
USA

-- 54 of 66 --

55
Vitality Global divided into two pillars, both designed to optimally
capture the global potential of Discovery IP
Vitality Network Vitality Health International
Product/
Service
Commercial
Model
to a global network of world-class
insurers in a highly cash-focused commercial
model
The
A fully integrated behavioural-change
programme underpinned by a supporting
tech platform, data & consulting services
Description
through successful equity
positions in a select number of high potential
HealthTech and health insurance ventures
HealthTech behaviour-change solutions for public
and private payers, and providers
Health insurance in fast-growing emerging markets
Shared-value health insurance approach
Global
Vitality
Network Vitality Health
International

-- 55 of 66 --

56
Vitality Global excluding Ping An Health
Vitality Global revenue Vitality Global operating
profit
2018 2019 2020 2021 2022
to $31.4m	to $100.4m
Integrated API by
Insurance Partners
to $1.4bn
2018 2019 2020 2021 2022
Insurance partners
membership
to 3m
2018 2019 2020 2021 2022
Vitality Network
2018 2019 2020 2021 2022
Insurance Markets
+29%
Vitality USA

-- 56 of 66 --

57
Vitality Network | Drivers of growth
41%
44%
56%
59%
64%
30%
35%
40%
45%
50%
55%
60%
65%
70%
200
400
600
800
1000
1200
1400
1600
Partner API &
penetration rates
API
Penetration
rates
2021 2022
Present value of existing contract revenues
This represents the sum of the future expected revenue from Vitality Group’s insurance
partnerships based on latest internal forecasts at a discount rate of risk-free + 10% at
each point in time for variable revenue and risk-free for guaranteed revenue
New
contracts
& sources
of income
Growth in
existing
markets above
expectations
Methodology
& assumption
changes
Economic
experience
variances
Expected PV of revenue from existing contracts
$989m
$1.1bn
FY18 FY19 FY20 FY21 FY22
Membership
(millions)
0.8
1.4
1.8
2.4
3.0
FY18 FY19 FY20 FY21 FY22
Integrated
products
101
128
160
182
191
FY18 FY19 FY20 FY21 FY22	FY18 FY19 FY20 FY21 FY22
14
18
21
27
30
Number of
Vitality Network
markets
+9% >$1bn
Growth enabled and fuelled by new products & new channels

-- 57 of 66 --

58
VHI | High potential HealthTech & insurance ventures in key geographies
USA
HEALTH
AFRICA
Health insurance
HealthTech
The largest and most profitable health insurer in China, with growth that exceeds competitors
lives
Digital health technology and solutions business, with an addressable market of US$100 billion
US corporate wellness business expanding into HealthTech
Pan African wholly owned subsidiary operating with local partners in different African countries
Joint venture providing advanced data science & predictive analytics services to health industry clients in multiple
regions
technology & health-IP assets developed over >30 years with >200 employees building the business
lives with an engagement rate that increased by 30% off an already high base rate
markets launched within first 6 months
increase in profits in FY22, with an increase in revenue of 22%

-- 58 of 66 --

59
Integrated capabilities across the entire health
insurance and healthcare value chain
>500m
unique claims
1bn
physical activity
data points
>10TB
behavioural
data
>10m
hospital
admissions
Extensive data sets
75% 25%
Transforming AIA through world-class technology
AIA providing initial capital and has a captive base of
~50m clients (>14m health and >160k corporates)
across 9 key geographies
Discovery is a global innovator in health insurance with
30 years of experience and execution track record
Capital-light and technology-centric insurtech business
>$100bn addressable market opportunity in Asia for
digital health and technology services by 2030
Symptom
checker &
triage
Patient
coaching
platform
Integrated
patient
management
Electronic
health
records
Mental
wellness
Virtual
consultations
Electronic
scripts &
delivery
Medicine
adherence
Nutrition &
weight
management
AIA Vitality
Digital Health
Platform and
Solutions
Integrated digital
health solutions
driving engagement,
greater convenience
and efficiencies
Disease
management
High-risk
patient
management
Disease
prevention
Care
co-ordination
Provider
integration
Advanced
illness
management
Payment
options
Family history
& risks
Case mngt
automation
Pricing
optimisation
Medical Cost
Optimisation
Digital tools and
analytics supporting
high-quality, cost-
effective care
Insurance
pricing
Underwriting
algorithms
Contract &
tariff mngt
Pharma
benefit mngt
Digital pre-
authorisation
Product
design
enhancement
Health claims
processing
Clinical data
integration
Complex
benefit STP
Formulary
mngt
Benefits and
Policy
Management
Highly flexible,
automated and agile
end-to-end policy
admin, claims and
benefit systems
Population
health
insights
Disease
burden
indices
Clinical
technology
Fraud, waste
& abuse
Policy
renewal
optimisation
Frequency &
utilisation
Clinical
auditing
Claims and
behaviour
Operational
improvement
Clinical
predictions
Data, Analytics
and Health
Intelligence
Advanced data
management and
analytics for
personalisation and
value generation

-- 59 of 66 --

60
progress update
Officially launched 1 March 2022
Full executive team and senior management layer appointed, and best-in-class technology and data
science teams appointed
194 total staff complement
Substantial progress in transfer of 5 major technology platforms from DSY to AIA – completed by end
2022
7 technology solutions being developed for implementation in AIA markets and for external public
and private clients in APAC region
First solution deployment underway in one of AIA’s large health insurance businesses
Extensive market development work with all AIA health insurance businesses almost completed – expected
to lead to substantial programme of solution deployment over next 5 years
Active engagement with potential government and private sector clients in Singapore
Significant progress towards acquisition of a leading AI and data analytics business in Singapore –
expected to be complete before end 2022

-- 60 of 66 --

61
Written premium1Lives
Ping An Health
1 100% of PAH
PAH’s operating
results pre-tax
to R2.5bn
(DSY’s share is R622m)
Discovery’s operating
result after tax
to R338m
2018 2019 2020 2021 2022
to R45.2bn
PAH
insurance
licence
PAH insurance licence
Reinsurance
PAH insurance licence
Reinsurance
RMB 6.57bn
2019 2020 2021 2022
Net assets
2018 2019 2020 2021 2022
Profit before investment income
and gains
Investment income and gains
profit growth
before
investment
income
2018 2019 2020 2021 2022
8.9
13.5
17.6 19.4	1.7
7.8
13.0 7.9
Jun-19 Jun-20 Jun-21 Jun-22

-- 61 of 66 --

62
2001 2004 2007 2010 2013 2016 2019
Out-of-pocket
Voluntary Insurance
Compulsory Contributions (SHI)
14.3% CAGR $189
$46
$300
China’s private health insurance prospects remain positive, despite
COVID-related headwinds
Short-term economic strain due to
COVID-related restrictions on
movement and activity
Medium-term economic outlook
remains positive
Private health insurance industry
set to build on strong fundamentals
High risk population remains under-
vaccinated
52m people > 60 years
unvaccinated1
Healthy China 2030
Rising middle-class with higher income
Middle class expected to
double in next decade
Higher income for aging
population over the next five
years
+100%
+26%
Severe GDP impact3
Policies emphasise developing
private healthcare and private
health insurance, amongst
others
Estimated GDP growth3
COVID-related excess deaths
potentially reaching 1.5 million2
5.5%
3.3%
2022 Target 2022 Forecast
0.4% growth
in Q2 2022
2022 EIU Forecast
5.0% 4.7% 4.4% 4.2%
2023 2024 2025 2026
Healthcare expenditure growing, including
private expenditure
(Current USD per capita)4
Source: 1. Economist April 2022 Edition; 2. Reuters 2022-05-10 ; 3. Economist Intelligence Unit, September 2022; 4. World Health Organisation, Global Health Expenditure Database

-- 62 of 66 --

63
2021 2022
Group channel
Non-PAL cross-selling
Other
PAL individual channel
Diversified distribution channels and continued expansion ensure
resilient and persistent growth in sales on PAH’s insurance licence
Shift towards non-PAL
channels
+51%
+31%
35% 42%
-9%
-23%
Distribution channels continue to expand both
offline and online
Beijin
g
Heb
ei
Tianji
n	
Jiangs
u
Shanghai
(HQs)	
Zheijian
g
Sichua
n
Guangdong
Shenzhe
n
Hen
an
Hubei
Liaoni
ng
Chongqi
ng
Shandong
Fujia
n
Huna
n
PAH licensed regions
PAH unlicensed regions
PAH licensed regions
represent 58% of GDP2
Offline branch network
16
Branches
Multi-channel online
distribution
Ping An Health
online
Ping An APPs
SuiShenYi
Online
management of
high-quality
advisor network
Expand PAH
operated WeChat
& APP channels
Partner with online
platforms in Ping
An Group
1 100% PAH | 2 Source: China statistical yearbook 2021 edition
2018 2019 2020 2021 2022
New business1
-15%
to R11.5bn
PAH
insurance
licence
+6%
PAH insurance licence
Reinsurance

-- 63 of 66 --

64
Ping An Health’s growth rate exceeds the market and profitability is
outperforming key competitors
CBIRC regional monthly premium data, commercial health insurance for medical reimbursement (excluding CI premium); published annual financial statements
PAH remains resilient during recent
difficult market conditions
63% group insurance growth rate,
ahead of competitors
Highest profit margins among
leading specialist health insurers
1.01
0.37 0.36
1.64
0.46
0.28
Ping An Health Cigna MSH
Premium income RMB billions
Premium income Jan-Jun 2022
Premium income Jan-Jun 2021
+63%
+26%
-22%
Company 2020 2021
Ping An Health
Insurance Company 5.4% 6.7%
Kunlun Health
Insurance Co Ltd -19.5% 2.7%
CPIC Health 2.1% 2.3%
PICC Health Insurance
Company Limited 0.8% 0.1%
Fosun United Health
Insurance Company Ltd 0.6% -3.4%
Ruihua Health
Assurance Corporation -7.9% -26.5%
Annual profitability analysis of top 6
specialist health insurers in China at
December 2021
Margin calculated as net profit/operating revenue
Total premium growth rate (%)
January to June 2022
-0.7%
22.6%
Health insurance
market average
premium growth
PAH premium
growth

-- 64 of 66 --

65
Positioned for growth off a strong foundation
The leading new generation financial services organisation which through its Vitality Shared-value
model makes customers healthier, provides better and more sustainable products, achieves superior growth
and returns for its shareholders and is a force for good in the communities in which it operates
Normalised
operating profit
+45%
to R9 384m
Normalised
headline earnings
+71%
to R5 816m
Headline
earnings
+74%
to R5 204m
+5% new business API, including DH take-
on of new closed schemes and gross
revenue for Vitality Group
Core new
business
+6%
to R21 710m

-- 65 of 66 --

AUDITED
RESULTS
for the year ended 30 June 2022

-- 66 of 66 --